Aspen Pharmacare poised to alleviate global obesity drug shortage
Aspen Pharmacare Holdings Ltd., Africa’s largest pharmaceutical company, stands poised to alleviate the global shortage of obesity medications.
pharmaceutical
Capital flows North. Ascendis Health spends R7.3bn on two acquisitions in Europe.
South Africa’s Ascendis Health bought two European companies as part of its plan to expand globally and diversify its pharmaceutical products.
đź”’ WEBINAR: Apple, Berkshire laggards
Alec Hogg takes us through the performance and current position of the Biznews.com Global Share Portfolio Webinar, which is proving to be highly successful.
Cipla wins R2bn state ARV tender
Cipla Medpro was awarded a R2 billion share of government’s 2015-2017 national anti-retrovirals (ARVs) tender, the company announced on Tuesday.
Stephen Saad’s Aspen: From JSE newcomer to R150bn valuation in 16 years
In 1998, Stephen Saad and Gus Attridge took their ambitions public through the reverse takeover by their year-old business into JSE-listed Medhold. A year later they pulled off a R2.4bn hostile takeover of the well resourced but poorly managed SA Druggists. And the rest is history. Now a multinational corporation, last week Aspen delivered another sparkling … Read more
The healthcare enquiry: expect significant intervention
In every country in the world, the healthcare industry is a target for a great deal of debate and argumentation. There are many conflicting pressures on the healthcare business. On the one hand, there is the pressure of social justice, which demands that all citizens be given access to the care needed to sustain life … Read more
Investing globally: the why and the how. Tips from adviser to South Africa’s ultra-rich
If the international investment bug hasn’t bitten you, it soon will. The prediction from Johan van Zyl, who heads an advisory service for South Africa’s ultra-rich, is that we are going to become increasingly interested in what the investment world has to offer beyond our borders. Although the sharp decline of our national currency is … Read more
Adcock Ingram: Next steps for pharmaceutical group as Bidvest takes command
After a protracted takeover battle, Bidvest is set to take control of South African pharmaceutical group Adcock Ingram (to see its share price and financials, visit the Biznews.com data bank:Â JSE:AIP). In this interview with Biznews.com editor Alec Hogg on CNBC Power lunch, investment expert Mark Ingham of Ingham Analytics explores what’s next for the company. … Read more
Bidvest’s Joffe victorious in War for Adcock Ingram – now he wants to win the Peace
I’ve been accused of bias in the battle for under-performing pharmaceuticals company Adcock Ingram. Biased, that is, in favour of Bidvest and its founder Brian Joffe, whose approaches were spurned by the Adcock board of directors in favour of an offer from Chilean group CFR. Â Whatever the perception of CFR’s super-helpers, they can accuse all … Read more
Why you should quit your job in 2014: Five great reasons to resign soon.
Sometimes the scariest short-term decisions turn out to be the sensible, safest bets for your long-term happiness and financial security. This is the message that is brought home time and again by people who were forced through redundancy or other reasons to leave a seemingly comfortable job and ended up finding great success by going … Read more